Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare clinical research policy

Executive Summary

CMS issues a 1proposed decision memorandum on its clinical trial policy national coverage determination July 19 with a request for public comment. The agency earlier announced it would reopen its consideration of changes to the policy to allow for additional public input (2"The Pink Sheet" July 16, 2007, p. 22). Originally issued in 2000, the policy sets parameters for coverage of routine medical costs under Medicare Part B for patients participating in clinical trials that meet certain criteria. The new proposal aims to clarify those standards and allows study sponsors or principal investigators to certify that their study has met them. Comments are requested by Aug. 18, and CMS plans to issue a final decision by Oct. 19...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel